Condition

Affective Disorders

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 9 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials9

Recruiting0

Common interventions22

Lead sponsors shown9

Clinical trials

9 shown

Arts-based Social Prescribing for Mental HealthNCT07137572 · 2025-09-04

COMPLETED

Reducing the Rate and Duration of Re-ADMISsions Among Patients With Unipolar Disorder and Bipolar Disorder Using Smartphone-based Monitoring and Treatment - The RADMIS TrialsNCT03033420 · 2017-05-15

COMPLETED

Depression and Diabetes Control TrialNCT02675257 · 2015-07-01

COMPLETED

Routine Outcome Monitoring in Mental Health OutpatientNCT02095457 · 2014-07-01

UNKNOWN

The Effects of Progressive Muscle Relaxation Therapy in Patients With SchizophreniaNCT03667729 · 2014-06-30

COMPLETED

Reduction of Cardiovascular Risk in Severe Mental IllnessNCT01182012 · 2010-08-01

UNKNOWN

A Pilot Study of Boredom in a Community Sample of Adolescents and a Clinical Sample of AdolescentsNCT00163865 · 2005-05-01

COMPLETED

Safety And Efficacy Study Of Ziprasidone In Pediatric Psychotic IllnessNCT00199940 · 2003-12-01

COMPLETED

Ziprasidone vs. Sertraline/Haloperidol in Psychotic DepressionNCT00340379 · 2003-04-01

COMPLETED

Common interventions

ZiprasidoneDRUG2 A smartphone-based monitoring system including a) an integrated feedback loop between patients and clinicians and b) context-aware CBT modulesDEVICE1 Activation of personal and social resourcesBEHAVIORAL1 Art PrescriptionOTHER1 Cognitive restructuring of diabetes-related problemsBEHAVIORAL1 Diabetes complicationsBEHAVIORAL1 Diabetes-related affective problems analysisBEHAVIORAL1 Diabetes-specific problem-solving therapyBEHAVIORAL1 Foot care: exercises, care & control, injuries, neuropathyBEHAVIORAL1 Frequent monitoring and feedbackBEHAVIORAL1 Goal definition regarding self-care/glycaemia/well-beingBEHAVIORAL1 Goal setting towards improvement of glycaemic controlBEHAVIORAL1 HaloperidolDRUG1 Health care and specific topics (e. g. blood pressure)BEHAVIORAL1 Healthy foods, cooking recommendations, recipesBEHAVIORAL1 Interventions to increase diabetes treatment motivationBEHAVIORAL1 Lifestyle counselingBEHAVIORAL1 progressive muscle relaxationBEHAVIORAL1 Reduction of barriers to self-care/glycaemic controlBEHAVIORAL1 SertralineDRUG1 Social aspects of living with diabetesBEHAVIORAL1 Sports, activities and exerciseBEHAVIORAL1

Mapped drugs appearing in these trials

Shared trial participation only; not evidence of efficacy or approval.

ziprasidone2 haloperidol1 sertraline1

Leading sponsors

Bayside Health 1 Consorci Hospitalari de Vic 1 Duke University 1 Forschungsinstitut der Diabetes Akademie Mergentheim 1 KAVADIA ELENI 1 Medical College of Wisconsin 1 Psychiatric Centre Rigshospitalet 1 Shalvata Mental Health Center 1 Taipei Medical University 1

Trial status mix

COMPLETED7

UNKNOWN2

Phase mix

NA5

PHASE42

PHASE21

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.